Predict your next investment

Corporation
HEALTHCARE | Disease Diagnosis
grail.com

See what CB Insights has to offer

Founded Year

2015

Stage

Acquired | Acquired

Total Raised

$2.005B

Valuation

$0000 

About GRAIL

GRAIL combines high-intensity sequencing, computer science, and large population-scale clinical studies to develop a blood test for early-stage cancer detection.On September 21st, 2020, GRAIL was acquired by Illumina at a valuation of $8B. At the time of the acquisition, Illumina, a prior investor in Grail owned 14.5% of the company’s outstanding shares which made the effective purchase price for Grail closer to $7 billion.

GRAIL Headquarter Location

1525 O'Brien Drive

Menlo Park, California, 94025,

United States

650-542-0372

Latest GRAIL News

UK starts world's biggest trial of blood test to detect over 50 types of cancer

Sep 13, 2021

UK starts world's biggest trial of blood test to detect over 50 types of cancer UK starts world's biggest trial of blood test to detect over 50 types of cancer The Galleri test looks at the DNA in a patient's blood to determine if any come from cancer cells. Earlier diagnosis of cancers leads to dramatically increased survival rates. The NHS said it wanted to recruit 140,000 volunteers in England to see how well the test worked as part of a randomised control trial Reuters Updated Sep 13, 2021, 8:55 AM IST Britain's state-run National Health Service will on Monday begin the world's biggest trial of Grail Inc's flagship Galleri blood test that can be used to detect more than 50 types of cancer before symptoms appear. The Galleri test looks at the DNA in a patient's blood to determine if any come from cancer cells. Earlier diagnosis of cancers leads to dramatically increased survival rates. The NHS said it wanted to recruit 140,000 volunteers in England to see how well the test worked as part of a randomised control trial. Half of the participants will have their blood sample screened with the Galleri test right away. "We need to study the Galleri test carefully to find out whether it can significantly reduce the number of cancers diagnosed at a late stage," said Peter Sasieni, professor of cancer prevention at King's College London. "The test could be a game changer for early cancer detection and we are excited to be leading this important research." Lung cancer is by far the most common cause of cancer death in the United Kingdom, accounting for around a fifth of all cancer deaths. Lung, bowel, prostate and breast cancers account for 45% of the United Kingdom's cancer deaths, the NHS said. U.S. life sciences company Illumina Inc said last month it had completed its $7.1 billion acquisition of Grail. Illumina said it will operate Grail separately from its existing business. TAGS:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing GRAIL

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned GRAIL in 7 CB Insights research briefs, most recently on Jul 13, 2021.

Expert Collections containing GRAIL

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

GRAIL is included in 6 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

T

The Digital Hospital

122 items

Startups recreating how healthcare is delivered

S

Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.

G

Google In Healthcare

61 items

The healthcare companies and initiatives that Google has invested in or is a part of

S

Sequoia Capital China Investments 2018-2019

149 items

D

Digital Health 150 (2019)

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

GRAIL Patents

GRAIL has filed 84 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • DNA
  • Genetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/22/2017

4/20/2021

Molecular biology, DNA, Biotechnology, Genetics, Molecular biology techniques

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/22/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/20/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, DNA, Biotechnology, Genetics, Molecular biology techniques

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

GRAIL Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

GRAIL Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.